Guidelines for the management of myeloproliferative neoplasms

@inproceedings{Choi2015GuidelinesFT,
  title={Guidelines for the management of myeloproliferative neoplasms},
  author={Chul Won Choi and Soo Mee Bang and Seongsoo Jang and Chul Won Jung and Hee-Jin Kim and Ho Young Kim and Soo-jeong Kim and Yeo Kyeoung Kim and Jinny Park and Jong-ho Won},
  booktitle={The Korean journal of internal medicine},
  year={2015}
}
Polycythemia vera, essential thrombocythemia, and primary myelofibrosis are collectively known as 'Philadelphia-negative classical myeloproliferative neoplasms (MPNs).' The discovery of new genetic aberrations such as Janus kinase 2 (JAK2) have enhanced our understanding of the pathophysiology of MPNs. Currently, the JAK2 mutation is not only a standard… CONTINUE READING